These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
499 related articles for article (PubMed ID: 25835067)
1. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate. Thongnopkoon T; Puttipipatkhachorn S Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067 [TBL] [Abstract][Full Text] [Related]
2. Stabilizing ability of surfactant on physicochemical properties of drug nanoparticles generated from solid dispersions. Thongnopkoon T; Puttipipatkhachorn S Drug Dev Ind Pharm; 2017 Jul; 43(7):1082-1092. PubMed ID: 28161991 [TBL] [Abstract][Full Text] [Related]
3. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier. Ghanavati R; Taheri A; Homayouni A Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614 [TBL] [Abstract][Full Text] [Related]
4. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Sethia S; Squillante E Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063 [TBL] [Abstract][Full Text] [Related]
5. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique. Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114 [TBL] [Abstract][Full Text] [Related]
6. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions. Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier. Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267 [TBL] [Abstract][Full Text] [Related]
8. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin. Dave RH; Patel AD; Donahue E; Patel HH Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470 [TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Patel RP; Patel MM Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141 [TBL] [Abstract][Full Text] [Related]
10. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357 [TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. Andrews GP; AbuDiak OA; Jones DS J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757 [TBL] [Abstract][Full Text] [Related]
12. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole. Dave RH; Patel HH; Donahue E; Patel AD Drug Dev Ind Pharm; 2013 Oct; 39(10):1562-72. PubMed ID: 23030270 [TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001). Moes JJ; Koolen SL; Huitema AD; Schellens JH; Beijnen JH; Nuijen B Int J Pharm; 2011 Nov; 420(2):244-50. PubMed ID: 21907780 [TBL] [Abstract][Full Text] [Related]
14. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets. Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300 [TBL] [Abstract][Full Text] [Related]
15. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems. Thenmozhi K; Yoo YJ Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323 [TBL] [Abstract][Full Text] [Related]
16. In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method. Xu WJ; Liu Y; Shi LL; Cui JH; Cao QR Pak J Pharm Sci; 2014 Nov; 27(6):1799-804. PubMed ID: 25362604 [TBL] [Abstract][Full Text] [Related]
17. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent. Wu K; Li J; Wang W; Winstead DA J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575 [TBL] [Abstract][Full Text] [Related]
18. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel. Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332 [TBL] [Abstract][Full Text] [Related]
19. Preparation and physicochemical characterization of binary and ternary ground mixtures of carvedilol with PVP and SLS aimed to improve the drug dissolution. Bolourchian N; Talamkhani Z; Nokhodchi A Pharm Dev Technol; 2019 Nov; 24(9):1115-1124. PubMed ID: 31282827 [TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process. Kim MS; Kim JS; Park HJ; Cho WK; Cha KH; Hwang SJ Int J Nanomedicine; 2011; 6():2997-3009. PubMed ID: 22162657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]